Thirty Madison

Overview
Activities
News
Telehealth?
Product stageSegments
Expansion
?
Asynchronous Store and Forward Service
?

Thirty Madison offers direct-to-consumer telehealth consultations, online prescriptions, and treatment delivery for chronic conditions. The specialist treatment is offered for a range of illnesses via four brands; Keeps (for men’s hair loss), Cove (for migraines), Nurx (for sexual and reproductive health), and Facet (for dermatology care).

As of June 2023, the company’s telehealth platform had provided treatment for almost 1 million people.

In February 2022, the telehealth unicorn announced it planned to merge with a specialty care platform Nurx in an all-stock deal. The company planned to widen its portfolio of products and services under the Thirty Madison brand via the acquisition. The integrated platform catered to nearly 750,000 patients, offering a range of specialty care services from birth control to chronic disease management. The combined company planned to grow its B2B operations via partnerships with national payers and employers. 

In June 2023, the company acquired assets from recently bankrupt online pharmacy provider The Pill Club in a deal valued at USD 32.3 million. The assets acquired include over 100,000 patient files, which will enable the company to provide continued care for those patients through its online birth control prescription plan, Nurx.

Key customers and partnerships

In April 2024 Thirty Madison partnered with Talkspace, an online therapy company, to bring mental health care to the former's members using its Nurx and Cove platforms. As part of the collaboration, Talkspace began providing therapy services to Nurx and Cove members via their respective platforms. While Nurx users already had access to treatments for depression and anxiety, along with medication management, the partnership provided Nurx and Cove members with the opportunity to connect with licensed therapists via Talkspace and benefit from its self-guided app. Talkspace users, on the other hand, were able to access migraine care from Cove and dermatological and reproductive health services for women from Nurx.

HQ location:
30 West 29th Street 4th Floor New York NY USA
Founded year:
2017
Employees:
251-500
IPO status:
Private
Total funding:
USD 229.5 mn
Last Funding:
USD 1.3 mn (Undisclosed; Apr 2024)
Last valuation:
USD 1.0 bn (Jun 2021)
Key competitors
Filter by the segments to which the disruptor belongs
All Segmentsexpand
 
Loading...
Loading...
Loading...
Loading...
Product Overview
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
Product Metrics
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
Company profile
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...

EDGE Insights

Funding data are powered by Crunchbase
arrow
menuarrow
Click here to learn more
Get a demo

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.